IP Library Granted Patent US 7,138,267
Granted Patent B1
US 7,138,267 · App. 10/116,886 · Granted Nov 21, 2006

Methods and compositions for amplifying DNA clone copy number

Assignee: Epicentre Technologies Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,138,267
App. No.
10/116,886
Granted
Nov 21, 2006
Kind
B1
Abstract

A method for retrofitting DNA in a single-copy or high-copy vector, such as a fosmid or BAC, whereby an artificial transposon is used to introduce a conditional multi-copy origin of replication (“ori”) into the DNA in said vector. Following random in vitro or in vivo transposition of the ori-containing transposon into DNA in the single-copy or low-copy vector, the resulting insertion clones are introduced into a special host strain that contains a gene which encodes a polypeptide required for replication from the multi-copy ori. However, since the gene for this polypeptide is expressed from a tightly-regulated inducible promoter, the polypeptide is not expressed in the absence of inducer. On addition of inducer to the culture medium, the host cell synthesizes the polypeptide, which in turn activates replication from the multi-copy ori, thereby increasing the amount of clone DNA synthesized by the cell.

Claims (4)

1. A host constructed using a method for constructing a bacterial host strain which, in the presence of an inducer, expresses a protein or polypeptide required for replication from a multi-copy ori, said method comprising in vivo insertion of a gene for said protein or polypeptide required for replication from a multi-copy ori into the chromosomal DNA of bacterial host by means of a synaptic complex between a transposase and an artificial transposon, said transposon comprising a gene encoding said protein or polypeptide required for replication from said multi-copy ori which is operably joined to an inducible promoter which results in, transcription of said gene and expression of said protein or polypeptide under suitable conditions in the presence of an inducer of said inducible promoter, wherein said artificial transposon comprises an artificial Tn5 transposon comprising hyperactive Mosaic End (ME) sequences and a trfA gene which is operably joined to an inducible araB promoter.

2. A bacterial host strain which, in the presence of L-arabinose, expresses the trfA Protein required for replication from an oriV origin of replication, said bacterial host strain comprising a trfA gene inserted in the chromosomal DNA of said bacterial host strain, wherein said trfA gene is operably joined to an araB promoter which results in transcription of said trfA gene and expression of said trfA Protein under suitable conditions in the presence of L-arabinose and wherein the inserted trfA gene is flanked by two 19-basepair ME sequences of a hyperactive Tn5 transposon.

3. The bacterial host strain of claim 2 wherein the trfA gene is inserted in a dpm1 gene.

4. The bacterial host strain of claim 2 wherein the bacterial host strain, in the presence of L-arabinose, expresses the TrfA Protein required for replication from an oriV origin of replication comprising SEQ ID No. 1.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 2, 2015
From: EPICENTRE TECHNOLOGIES CORPORATION
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 035813/0191 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2002
From: JENDRISAK, JEROME J.; HOFFMAN, LESLIE M.; FIANDT, MICHAEL J.; HASKINS, DARIN
To: EPICENTRE TECHNOLOGIES CORPORATION
Reel/Frame 013239/0566 →
Continuity (1)
Provisional Application 6028162400 · Apr 4, 2001